Get Patent Opposition Report for Pharma Stulln

Comprehensive Analysis, Strategic Insights & Expert Evaluation – Stay Ahead in Your Patent Challenge.

Download Your Report Now

Explore patent oppositions filed by Pharma Stulln against competitors, revealing strategic technology disputes and market positioning. Monitor opposition details, timelines, and disputed innovations to understand competitive dynamics and IP enforcement strategy.

Patent NumberTitleApplicantOpposition Date
EP3548000Atropine Pharmaceutical CompositionsNEVAKARAug 9, 2022
EP3426226Ophthalmological CompositionURSAPHARM ARZNEIMITTELJun 9, 2022
EP2429507Phosphate-Free Pharmaceutical Composition For The Treatment Of GlaucomaURSAPHARM ARZNEIMITTELApr 17, 2018